UBS downgraded Braskem (BAK) to Neutral from Buy with a price target of $3.80, down from $5.10. The firm sees a tough backdrop for spreads, including a deterioration in the short-term outlook. UBS is more conservative on shares of Braskem as it sees no easy path to ceasing its cash consumption without a potential asset sale.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAK:
- Braskem Faces Credit Downgrade Amidst Petrochemical Industry Challenges
- Braskem S.A. Reports No Securities Transactions in August 2025
- Braskem S.A. Reports August 2025 Securities and Derivatives Activities
- Braskem Idesa Engages Advisors for Capital Structure Review Amid Economic Challenges
- Hold Rating for Braskem S.A. Amid Regulatory and Market Uncertainties